Julian Staniek

PhD Student

Medical Center – University of Freiburg

Department of Rheumatology and Clinical Immunology & Center for Chronic Immunodeficiency

2015 – present PhD student in the lab of Dr. Marta Rizzi, Center for Chronic Immunodeficiency (CCI) & Department of Internal Medicine, Rheumatology and Clinical Immunology, Medical Center - University of Freiburg
2012 – 2014 M. Sc. in Biology, University of Freiburg, Germany
2008 – 2011 B. Sc. in Biology, University of Tübingen, Germany

Publications based on CRC1160 funding

Troilo, A., C. Wehr, I. Janowska, N. Venhoff, J. Thiel, J. Rawluk, N. Frede, J. Staniek, R. Lorenzetti, M. T. Schleyer, G. W. Herget, L. Konstantinidis, M. Erlacher, M. Proietti, N. Camacho-Ordonez, R. E. Voll, B. Grimbacher, K. Warnatz, U. Salzer, and M. Rizzi. 2020. Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiency. Blood 135: 1452-1457.

Lorenzetti R, Janowska I, Smulski CR, Frede N, Henneberger N, Walter L, Schleyer MT, Hüppe JM, Staniek J, Salzer U, Venhoff A, Troilo A, Voll RE, Venhoff N, Thiel J, Rizzi M. 2019. Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. J Autoimmun. 101:145-152.

Staniek J, Lorenzetti R, Heller B, Janowska I, Schneider P, Unger S, Warnatz K, Seidl M, Venhoff N, Thiel J, Smulski CR, Rizzi M. 2019. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes. Front Immunol. 10:951.

Rizzi, M., R. Lorenzetti, K. Fischer, J. Staniek, I. Janowska, A. Troilo, V. Strohmeier, M. Erlacher, M. Kunze, B. Bannert, D. Kyburz, E. Voll, N. Venhoff, and J. Thiel. 2017. Impact of tofacitinib treatment on human B-cells in vitro and in vivo. J Autoimmun 77: 55-66.